Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dyck, P. J.
Right arrow Articles by Swanson, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dyck, P. J.
Right arrow Articles by Swanson, C. J.
NEUROLOGY 1986;36:1300
© 1986 American Academy of Neurology

Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis

Peter James Dyck, MD, Jeannine Karnes, MS, Peter C. O'Brien, PhD and Carol J. Swanson

Peripheral Neuropathy Research Laboratory (Dr. Dyck, Ms. Karnes, and Ms. Swanson), and the Section of Medical Research Statistics (Dr. O'Brien), Mayo Clinic and Mayo Foundation, Rochester, MN.

We developed a true-or-false questionnaire with several hundred questions about symptoms encountered in peripheral neuropathy, to be scored by optical reader and computer. Responses were grouped into scales called "Neuropathy," "Weakness," "Sensory," "Autonomic," and subsets of these. Profiles in health were estimated for each scale based on responses from 300 healthy subjects 15 to 65 years old. The sensitivity and specificity of the scales were tested in patients with motor neuron disease, amyloidosis, or diabetes, with or without neuropathy. The questionnaire was useful in detecting neuropathy and staging severity, and in recognizing patterns that may have diagnostic implications.

Address correspondence and reprint requests to Dr. Dyck, Peripheral Neuropathy Research Laboratory, Mayo Clinic. 200 First Street SW, Rochester, MN 55905.

Supported in part by a grant from Whirlpool Corporation, a Peripheral Neuropathy Clinical Center Grant from NINCDS (NS-14304), a Center Grant from MDA, Mayo Foundation, and the Borchard and Upton Funds.

Accepted for publication February 25, 1986.




This article has been cited by other articles:


Home page
Diabetes CareHome page
C. L. Martin, J. Albers, W. H. Herman, P. Cleary, B. Waberski, D. A. Greene, M. J. Stevens, and E. L. Feldman
Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion
Diabetes Care, February 1, 2006; 29(2): 340 - 344.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. H.M. van Schie, C. Vermigli, A. L. Carrington, and A. Boulton
Muscle Weakness and Foot Deformities in Diabetes: Relationship to neuropathy and foot ulceration in Caucasian diabetic men
Diabetes Care, July 1, 2004; 27(7): 1668 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Einarsdottir, A. Carlsson, J. Minde, G. Toolanen, O. Svensson, G. Solders, G. Holmgren, D. Holmberg, and M. Holmberg
A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception
Hum. Mol. Genet., April 15, 2004; 13(8): 799 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J-P Lefaucheur and A Creange
Neurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathy
J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(3): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. H. Riihimaa, K. Suominen, U. Tolonen, V. Jäntti, M. Knip, and P. Tapanainen
Peripheral Nerve Function Is Increasingly Impaired During Puberty in Adolescents With Type 1 Diabetes
Diabetes Care, June 1, 2001; 24(6): 1087 - 1092.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
D. Maleki, G. R. Locke III, M. Camilleri, A. R. Zinsmeister, B. P. Yawn, C. Leibson, and L. J. Melton III
Gastrointestinal Tract Symptoms Among Persons With Diabetes Mellitus in the Community
Arch Intern Med, October 9, 2000; 160(18): 2808 - 2816.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. R. Cornblath, V. Chaudhry, K. Carter, D. Lee, M. Seysedadr, M. Miernicki, and T. Joh
Total neuropathy score: Validation and reliability study
Neurology, November 1, 1999; 53(8): 1660 - 1660.
[Abstract] [Full Text]


Home page
NeurologyHome page
J. E. Riggs, S. C. Apfel, W. J. Litchy, J. A. Kessler, C. Sanders, B. T. Adornato, and C. A. Rask
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
Neurology, April 1, 1999; 52(7): 1517 - 1517.
[Full Text]


Home page
NeurologyHome page
G. A. Suarez, T. L. Opfer-Gehrking, K. P. Offord, E. J. Atkinson, P. C. O'Brien, and P. A. Low
The Autonomic Symptom Profile: A new instrument to assess autonomic symptoms
Neurology, February 1, 1999; 52(3): 523 - 523.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. C. McArthur, E. A. Stocks, P. Hauer, D. R. Cornblath, and J. W. Griffin
Epidermal Nerve Fiber Density: Normative Reference Range and Diagnostic Efficiency
Arch Neurol, December 1, 1998; 55(12): 1513 - 1520.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.